Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children

BACKGROUND
1 Introduction to Lipids and Lipoproteins Kenneth R. Feingold, MD
2 The Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders Ernst J Schaefer, Fumiyoshi Tsunoda, Margaret Diffenderfer, Eliana Polisecki, Ngoc Thai and Bela Asztalos
3 Utility of Advanced Lipoprotein Testing in Clinical Practice Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
4 The Role of Lipids and Lipoproteins in Atherosclerosis MacRae F. Linton, MD, Patricia G. Yancey, PhD, Sean S. Davies, PhD, W. Gray (Jay) Jerome, PhD, Edward F. Linton, BA, Wenliang L. Song, MD, Amanda C. Doran, PhD, MD and Kasey C. Vickers, PhD
5 Guidelines for the Management of High Blood Cholesterol Scott M. Grundy, MD and Kenneth R. Feingold, MD
6 Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis Deval Bhatt, M.D. and Lisa Tannock, MD
GENETIC DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM
7 Familial Hypercholesterolemia: Genes and Beyond Bruce A. Warden PharmD, BCPS-AQ Cardiology, CLS, FNLA, FASPC, Sergio Fazio MD, PhD and Michael D. Shapiro, DO, MCR
8 Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment Alan Chait, MD and Savitha Subramanian, MD
9 Lysosomal Acid Lipase Deficiency Don P. Wilson, MD, FNLA and Nivedita Patni, MD
10 Sitosterolemia Ann Liebeskind, MD, Amy L. Peterson, MD and Don P. Wilson, MD, FNLA
11 Cerebrotendinous Xanthomatosis Nivedita Patni, MD and Don P. Wilson, MD, FNLA
12 Lipoprotein (a) Catherine J. McNeal, MD, PhD and Amy L. Peterson, MD
13 Monogenic Disorders Causing Hypobetalipoproteinemia Michael D. Shapiro, DO, MCR and Kenneth R. Feingold, MD
14 Monogenic Disorders Altering HDL Levels Michael D. Shapiro, DO, MCR and Kenneth R. Feingold, MD
15 Lipodystrophy Syndromes: Presentation and Treatment Baris Akinci, Melis Sahinoz and Elif Oral
SECONDARY DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM AND SPECIAL POPULATIONS
16 Dyslipidemia in Diabetes Kenneth R. Feingold, MD
17 Dyslipidemia in Chronic Kidney Disease Lisa Tannock, MD
18 Lipid and Lipoprotein Metabolism in Liver Disease David E. Cohen MD, PhD and Kathleen E. Corey MD MPH, MMSc
19 The Effect of Endocrine Disorders on Lipids and Lipoproteins Kenneth R. Feingold, MD, Eliot A. Brinton, MD, FAHA, FNLA and Carl Grunfeld, MD, PhD
20 The Effect of Inflammation and Infection on Lipids and Lipoproteins Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
21 Lipid Disorders In People With HIV Sudipa Sarkar, MD, MSCI and Todd T. Brown MD, PhD
22 Lipid and Lipoprotein Levels in Patients with Covid-19 Infections Kenneth R. Feingold, MD
23 Medication Induced Changes in Lipid and Lipoproteins Megan Herink, Pharm.D., BCPS and Matthew K. Ito, Pharm.D., FCCP, FNLA, CLS.
24 Obesity and Dyslipidemia Kenneth R. Feingold, MD
25 Management of Dyslipidemia in the Elderly Elani Streja, Ph.D. and Dan Streja, MD, FRCPC, FACP, FACE,
26 Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels Sarah B. Grimes, MD and Robert Wild, MD, MPH, PhD
TREATMENT
27 Approach to the Patient with Dyslipidemia Kenneth R. Feingold, MD
28 The Effect of Diet on Cardiovascular Disease and Lipid and Lipoprotein Levels Kenneth R. Feingold, MD
29 Cholesterol Lowering Drugs Kenneth R. Feingold, MD
30 Triglyceride Lowering Drugs Kenneth R. Feingold, MD
31 Lipoprotein Apheresis Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
PEDIATRIC LIPIDOLOGY
BACKGROUND
32 Is Atherosclerosis a Pediatric Disease Don P. Wilson, MD, FNLA
33 Fetal and Neonatal Cholesterol Metabolism Laura Woollett and James E Heubi
34 Non-Invasive Techniques In Pediatric Dyslipidemia Damon B. Dixon, MD
35 Principles of Genetic Testing for Dyslipidemia in Children Luke Hamilton, MS, Ariel Brautbar, MD and Don P. Wilson, MD, FNLA
36 Genetics and Dyslipidemia Nivedita Patni, MD, Zahid Ahmad, MD and Don P. Wilson, MD, FNLA
SCREENING AND GUIDELINES
37 Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents Stephen R. Daniels, MD, PhD
38 Lipid Screening in Youth Lindsay Eilers, MD and Justin P. Zachariah MD MPH
HYPERCHOLESTEROLEMIA
39 Ethical Dilemmas in Pediatric Lipidology G. Kevin Donovan, MD, MA and Don P. Wilson, MD, FNLA
40 Familial Hypercholesterolemia Amy E. Levenson, MD and Sarah D. de Ferranti, MD, MPH
41 Lysosomal Acid Lipase Deficiency Don P. Wilson, MD, FNLA and Nivedita Patni, MD
42 Sitosterolemia in the Pediatric Population Ann Liebeskind, MD, Amy L. Peterson, MD and Don P. Wilson, MD, FNLA
43 Cerebrotendinous Xanthomatosis Nivedita Patni, MD and Don P. Wilson, MD, FNLA
44 Lipoprotein (a) in Youth Catherine J. McNeal, MD, PhD and Amy L. Peterson, MD
HYPERTRIGLYCERIDEMIA
45 Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents Amy S. Shah, MD MS. and Don P. Wilson, MD, FNLA
46 Secondary Hypertriglyceridemia Irwin Benuck, MD, PhD, Don P. Wilson, MD, FNLA and Catherine J. McNeal, MD, PhD
TREATMENT
47 Combined Dyslipidemia in Children and Adolescents Rae-Ellen W. Kavey, MD, MPH.
48 Nutritional Management of Pediatric Dyslipidemia Lauren A. Williams, MCN, RD and Don P. Wilson, MD, FNLA
49 Use of Lipid Lowering Medications in Youth Melissa L Miller, PharmD, Chanin C Wright, PharmD. and Brandi Rodriguez, PharmD
50 A Clinical Approach to Aggressive Treatment of Children with Severe Hypertriglyceridemia Alejandro De La Torre, MD, Luke Hamilton, MS and Don P. Wilson, MD, FNLA
51 Clinical Management of Dyslipidemia in Youth with Chronic Kidney Disease Alejandro De La Torre, MD, Nivedita Patni, MD and Don P. Wilson, MD, FNLA